Managing the significant drug-drug interaction between tacrolimus and letermovir in solid organ transplant recipients

Clin Transplant. 2021 Mar;35(3):e14213. doi: 10.1111/ctr.14213. Epub 2021 Jan 13.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acetates
  • Drug Interactions
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Organ Transplantation*
  • Pharmaceutical Preparations*
  • Quinazolines
  • Tacrolimus / adverse effects
  • Transplant Recipients

Substances

  • Acetates
  • Immunosuppressive Agents
  • Pharmaceutical Preparations
  • Quinazolines
  • letermovir
  • Tacrolimus